Viewing Study NCT02325557


Ignite Creation Date: 2025-12-24 @ 6:31 PM
Ignite Modification Date: 2025-12-25 @ 4:01 PM
Study NCT ID: NCT02325557
Status: COMPLETED
Last Update Posted: 2024-04-02
First Post: 2014-12-22
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Sponsor: Advaxis, Inc.
Organization: